Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Relative mRNA Expression Levels of Restriction Factors and Antiviral Genes in Fetal and Adult Human Monocytes and Monocyte-Derived Macrophages.

Trang K, Raposo RA, Lowe MM, Krow-Lucal ER, Yonemoto W, Cabido VD, SenGupta D, McCune JM.

Viral Immunol. 2017 Apr;30(3):142-148. doi: 10.1089/vim.2016.0160. Epub 2017 Feb 2.

2.

Novel targets for HIV therapy.

Greene WC, Debyser Z, Ikeda Y, Freed EO, Stephens E, Yonemoto W, Buckheit RW, Esté JA, Cihlar T.

Antiviral Res. 2008 Dec;80(3):251-65. doi: 10.1016/j.antiviral.2008.08.003. Epub 2008 Sep 30.

PMID:
18789977
3.

Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.

Santiago ML, Montano M, Benitez R, Messer RJ, Yonemoto W, Chesebro B, Hasenkrug KJ, Greene WC.

Science. 2008 Sep 5;321(5894):1343-6. doi: 10.1126/science.1161121.

5.
6.

Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement.

Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC.

J Immunol. 2005 Nov 1;175(9):6050-7.

7.

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC.

Nature. 2005 May 5;435(7038):108-14. Epub 2005 Apr 13. Retraction in: Nature. 2010 Jul 8;466(7303):276.

PMID:
15829920
8.

HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion.

Cavrois M, Neidleman J, Yonemoto W, Fenard D, Greene WC.

Virology. 2004 Oct 10;328(1):36-44.

9.

HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.

Stopak K, de Noronha C, Yonemoto W, Greene WC.

Mol Cell. 2003 Sep;12(3):591-601.

10.

Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis.

Stoddart CA, Geleziunas R, Ferrell S, Linquist-Stepps V, Moreno ME, Bare C, Xu W, Yonemoto W, Bresnahan PA, McCune JM, Greene WC.

J Virol. 2003 Feb;77(3):2124-33.

11.

Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1.

Keppler OT, Yonemoto W, Welte FJ, Patton KS, Iacovides D, Atchison RE, Ngo T, Hirschberg DL, Speck RF, Goldsmith MA.

J Virol. 2001 Sep;75(17):8063-73.

12.
13.

A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor.

Bresnahan PA, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene WC.

Curr Biol. 1998 Nov 5;8(22):1235-8.

14.

Diminished spontaneous apoptosis in lymphocytes from human immunodeficiency virus-infected long-term nonprogressors.

Liegler TJ, Yonemoto W, Elbeik T, Vittinghoff E, Buchbinder SP, Greene WC.

J Infect Dis. 1998 Sep;178(3):669-79.

PMID:
9728534
15.

Autophosphorylation of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli.

Yonemoto W, McGlone ML, Grant B, Taylor SS.

Protein Eng. 1997 Aug;10(8):915-25.

PMID:
9415441
16.

Identification of phosphorylation sites in the recombinant catalytic subunit of cAMP-dependent protein kinase.

Yonemoto W, Garrod SM, Bell SM, Taylor SS.

J Biol Chem. 1993 Sep 5;268(25):18626-32.

17.

cAMP-dependent protein kinase defines a family of enzymes.

Taylor SS, Zheng J, Radzio-Andzelm E, Knighton DR, Ten Eyck LF, Sowadski JM, Herberg FW, Yonemoto WM.

Philos Trans R Soc Lond B Biol Sci. 1993 Jun 29;340(1293):315-24. Review.

PMID:
8103934
18.

N-myristylation of the catalytic subunit of cAMP-dependent protein kinase conveys structural stability.

Yonemoto W, McGlone ML, Taylor SS.

J Biol Chem. 1993 Feb 5;268(4):2348-52.

19.

Crystal structures of the catalytic subunit of cAMP-dependent protein kinase reveal general features of the protein kinase family.

Taylor SS, Radzio-Andzelm E, Knighton DR, Ten Eyck LF, Sowadski JM, Herberg FW, Yonemoto W, Zheng J.

Receptor. 1993 Fall;3(3):165-72. Review.

PMID:
8167567
20.

DdPK3, which plays essential roles during Dictyostelium development, encodes the catalytic subunit of cAMP-dependent protein kinase.

Mann SK, Yonemoto WM, Taylor SS, Firtel RA.

Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10701-5.

21.

Mammalian cAMP-dependent protein kinase functionally replaces its homolog in yeast.

Zoller MJ, Yonemoto W, Taylor SS, Johnson KE.

Gene. 1991 Mar 15;99(2):171-9.

PMID:
2022331
22.

Functional expression of mammalian adenosine cyclic monophosphate-dependent protein kinase in Saccharomyces cerevisiae.

Zoller MJ, Johnson KE, Yonemoto WM, Levin L.

Methods Enzymol. 1991;200:605-27.

PMID:
1956338
23.

Prokaryotic expression of catalytic subunit of adenosine cyclic monophosphate-dependent protein kinase.

Yonemoto WM, McGlone ML, Slice LW, Taylor SS.

Methods Enzymol. 1991;200:581-96. No abstract available.

PMID:
1956337
24.

Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.

Duronio RJ, Jackson-Machelski E, Heuckeroth RO, Olins PO, Devine CS, Yonemoto W, Slice LW, Taylor SS, Gordon JI.

Proc Natl Acad Sci U S A. 1990 Feb;87(4):1506-10.

25.

cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes.

Taylor SS, Buechler JA, Yonemoto W.

Annu Rev Biochem. 1990;59:971-1005. Review.

PMID:
2165385
26.

cAMP-dependent protein kinase: a framework for a diverse family of enzymes.

Taylor SS, Buechler JA, Slice LW, Knighton DK, Durgerian S, Ringheim GE, Neitzel JJ, Yonemoto WM, Sowadski JM, Dospmann W.

Cold Spring Harb Symp Quant Biol. 1988;53 Pt 1:121-30. Review. No abstract available.

PMID:
3076077
27.

Characterization of the altered form of the c-src gene product in neuronal cells.

Brugge J, Cotton P, Lustig A, Yonemoto W, Lipsich L, Coussens P, Barrett JN, Nonner D, Keane RW.

Genes Dev. 1987 May;1(3):287-96.

28.
29.

Investigations of the expression of the cellular src gene product.

Brugge JS, Yonemoto W, Lustig A, Golden A.

Princess Takamatsu Symp. 1986;17:241-9.

PMID:
3138228
30.

A 90,000-dalton binding protein common to both steroid receptors and the Rous sarcoma virus transforming protein, pp60v-src.

Schuh S, Yonemoto W, Brugge J, Bauer VJ, Riehl RM, Sullivan WP, Toft DO.

J Biol Chem. 1985 Nov 15;260(26):14292-6.

31.

Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen.

Yonemoto W, Jarvis-Morar M, Brugge JS, Bolen JB, Israel MA.

Proc Natl Acad Sci U S A. 1985 Jul;82(14):4568-72.

32.

Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.

Bolen JB, Thiele CJ, Israel MA, Yonemoto W, Lipsich LA, Brugge JS.

Cell. 1984 Oct;38(3):767-77.

PMID:
6091900
34.

The association of the transforming protein of Rous sarcoma virus with two cellular phosphoproteins.

Brugge JS, Darrow D, Lipsich LA, Yonemoto W.

Prog Clin Biol Res. 1983;119:135-47. No abstract available.

PMID:
6191339

Supplemental Content

Loading ...
Support Center